142 related articles for article (PubMed ID: 12551736)
1. Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
Burger ME; Alves A; Callegari L; Athayde FR; Nogueira CW; Zeni G; Rocha JB
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):135-40. PubMed ID: 12551736
[TBL] [Abstract][Full Text] [Related]
2. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain.
Burger ME; Fachinetto R; Zeni G; Rocha JB
Pharmacol Biochem Behav; 2005 Jul; 81(3):608-15. PubMed ID: 15953628
[TBL] [Abstract][Full Text] [Related]
3. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide.
Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB
Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469
[TBL] [Abstract][Full Text] [Related]
4. (-) Epigallocatechin-3-gallate attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum.
Wang MH; Lin RF; Tseng HC; Soung HS; Chang KC; Tsai CC
Pharmacol Biochem Behav; 2015 Apr; 131():71-6. PubMed ID: 25668129
[TBL] [Abstract][Full Text] [Related]
5. Effects of buspirone on an animal model of tardive dyskinesia.
Queiroz CM; Frussa-Filho R
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Nov; 23(8):1405-18. PubMed ID: 10631766
[TBL] [Abstract][Full Text] [Related]
6. Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats.
Burger ME; Fachineto R; Alves A; Callegari L; Rocha JB
Brain Res; 2005 Jan; 1031(2):202-10. PubMed ID: 15649445
[TBL] [Abstract][Full Text] [Related]
7. Effects of diphenyl-diselenide on orofacial dyskinesia model in rats.
Burger ME; Fachinetto R; Wagner C; Perottoni J; Pereira RP; Zeni G; Rocha JB
Brain Res Bull; 2006 Jun; 70(2):165-70. PubMed ID: 16782505
[TBL] [Abstract][Full Text] [Related]
8. Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.
Sanghavi CR; Barhate SA; Mahajan MS; Mohan M; Kasture SB
Nat Prod Res; 2011 Apr; 25(7):704-15. PubMed ID: 20628966
[TBL] [Abstract][Full Text] [Related]
9. Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors.
Cunha AS; Matheus FC; Moretti M; Sampaio TB; Poli A; Santos DB; Colle D; Cunha MP; Blum-Silva CH; Sandjo LP; Reginatto FH; Rodrigues AL; Farina M; Prediger RD
Behav Brain Res; 2016 Oct; 312():64-76. PubMed ID: 27306571
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats.
Abílio VC; Araujo CC; Bergamo M; Calvente PR; D'Almeida V; Ribeiro Rde A; Frussa-Filho R
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):109-14. PubMed ID: 12551732
[TBL] [Abstract][Full Text] [Related]
11. Additive pro-oxidative effects of methylmercury and ebselen in liver from suckling rat pups.
Farina M; Soares FA; Zeni G; Souza DO; Rocha JB
Toxicol Lett; 2004 Feb; 146(3):227-35. PubMed ID: 14687760
[TBL] [Abstract][Full Text] [Related]
12. Gallic acid decreases vacuous chewing movements induced by reserpine in rats.
Reckziegel P; Peroza LR; Schaffer LF; Ferrari MC; de Freitas CM; Bürger ME; Fachinetto R
Pharmacol Biochem Behav; 2013 Mar; 104():132-7. PubMed ID: 23313549
[TBL] [Abstract][Full Text] [Related]
13. Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats.
Queiroz CM; Piovezan RD; Frussa-Filho R
Eur J Pharmacol; 1998 Sep; 356(2-3):105-8. PubMed ID: 9774239
[TBL] [Abstract][Full Text] [Related]
14. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
Naidu PS; Singh A; Kulkarni SK
Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
[TBL] [Abstract][Full Text] [Related]
15. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.
Pereira RP; Fachinetto R; de Souza Prestes A; Wagner C; Sudati JH; Boligon AA; Athayde ML; Morsch VM; Rocha JB
J Neural Transm (Vienna); 2011 Nov; 118(11):1547-57. PubMed ID: 21476069
[TBL] [Abstract][Full Text] [Related]
16.
Soung HS; Wang MH; Chang KC; Chen CN; Chang Y; Yang CC; Tseng HC
Neurotox Res; 2018 Oct; 34(3):375-387. PubMed ID: 29629512
[TBL] [Abstract][Full Text] [Related]
17. Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors.
Raghavendra V; Naidu PS; Kulkarni SK
Brain Res; 2001 Jun; 904(1):149-52. PubMed ID: 11516422
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats.
Nade VS; Shendye NV; Kawale LA; Patil NR; Khatri ML
Neurochem Int; 2013 Oct; 63(4):316-21. PubMed ID: 23871717
[TBL] [Abstract][Full Text] [Related]
19. Effects of age on a new animal model of tardive dyskinesia.
Bergamo M; Abílio VC; Queiroz CM; Barbosa-Júnior HN; Abdanur LR; Frussa-Filho R
Neurobiol Aging; 1997; 18(6):623-9. PubMed ID: 9461060
[TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of MK-801 on reserpine-treated mice.
Dutra RC; Andreazza AP; Andreatini R; Tufik S; Vital MA
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):487-95. PubMed ID: 11999899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
